Silvia Martina Ferrari
Overview
Explore the profile of Silvia Martina Ferrari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
4380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elia G, Ferrari S, Tkachenko I, Walunj D, Balestri E, Botrini C, et al.
Endocrine
. 2024 Nov;
87(3):1050-1059.
PMID: 39570323
Purpose: New drugs are needed for the therapy of anaplastic thyroid cancer (ATC). This study aims to investigate doxorubizen (a dual-action structural hybrid (chimera) of doxorubicin (Dox) and DNA methylating...
2.
Ferrari S, Patrizio A, Stoppini G, Elia G, Ragusa F, Balestri E, et al.
Expert Opin Pharmacother
. 2024 Aug;
25(12):1667-1676.
PMID: 39161995
Introduction: Oncogenic tyrosine kinases (TK) are enzymes that play a key role in cell growth and proliferation and their mutations can lead to uncontrolled cell growth and development of aggressive...
3.
Fallahi P, Ragusa F, Patrizio A, Mazzi V, Botrini C, Elia G, et al.
Front Endocrinol (Lausanne)
. 2024 Jul;
15:1386629.
PMID: 39027476
Introduction: This is an observational and retrospective study, in which we have analyzed data from patients affected by gastric diseases (p) who have been treated with liquid L-T4 (L-LT4;84 p),...
4.
Ferrari S, Ragusa F, Elia G, Mazzi V, Balestri E, Botrini C, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928438
Anaplastic thyroid cancer (ATC) is one of the deadliest human cancers and represents <2% of thyroid carcinomas. A therapeutic target for ATC is represented by anaplastic lymphoma kinase (ALK) rearrangements,...
5.
Spinelli C, Ghionzoli M, Sahli L, Visintainer S, Guglielmo C, Cordola C, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893231
Background And Aims: This paper aims to study an alternative solution to hormonal replacement therapy in specific groups of patients who underwent thyroidectomy during childhood or adulthood. After cryopreservation, thyroid...
6.
Patrizio A, Ferrari S, Elia G, Ragusa F, Balestri E, Botrini C, et al.
Front Endocrinol (Lausanne)
. 2024 Jun;
15:1408684.
PMID: 38887272
Cardiovascular disease (CVD) remains the leading cause of death worldwide, representing a major health issue of social and economic relevance. Both hyperthyroidism and hypothyroidism are very common in the adult...
7.
Ferrari S, Patrizio A, Mazzi V, Ragusa F, Botrini C, Elia G, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1386510.
PMID: 38665263
In hypothyroid patients needing large doses of levothyroxine (L-T4) (>1.7-2 μg/kg/day) to reach euthyroidism, lactose intolerance (LI) needs to be excluded, owing to the high prevalence in the population. If...
8.
Stramazzo I, Mangino G, Capriello S, Romeo G, Ferrari S, Fallahi P, et al.
J Endocrinol Invest
. 2024 Apr;
47(11):2865-2871.
PMID: 38642306
Background: CD20 T cells represent up to 5% of circulating T lymphocytes. These cells have been shown to produce higher levels of IL-17A and IFN-γ than those of CD20 T...
9.
Spinelli C, Ghionzoli M, Ugolini C, Oreglio C, Guglielmo C, Morabito A, et al.
Eur Arch Otorhinolaryngol
. 2024 Apr;
281(7):3791-3796.
PMID: 38594507
Purpose: The purpose of the present study is to analyze thyroglossal duct cyst (TGDC) histopathological features, with focus on "arborization", in a cohort of pediatric patients who underwent surgical removal,...
10.
Fallahi P, Patrizio A, Stoppini G, Elia G, Ragusa F, Paparo S, et al.
Curr Oncol
. 2023 Dec;
30(12):10237-10248.
PMID: 38132379
Background: Papillary thyroid carcinoma (PTC) is the most common type of differentiated TC, while medullary TC (MTC) accounts for 4%. The concomitant presence of PTC and MTC is rare. Methods:...